BE512653A - - Google Patents
Info
- Publication number
- BE512653A BE512653A BE512653DA BE512653A BE 512653 A BE512653 A BE 512653A BE 512653D A BE512653D A BE 512653DA BE 512653 A BE512653 A BE 512653A
- Authority
- BE
- Belgium
- Prior art keywords
- esters
- androstane
- hydroxy
- aliphatic
- parts
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 150000001441 androstanes Chemical class 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 150000007513 acids Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- -1 aliphatic sulfonates Chemical class 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 238000003776 cleavage reaction Methods 0.000 claims description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 238000005755 formation reaction Methods 0.000 claims description 3
- 150000004702 methyl esters Chemical class 0.000 claims description 3
- 125000004043 oxo group Chemical group O=* 0.000 claims description 3
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 210000004940 Nucleus Anatomy 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 description 2
- 229960000583 Acetic Acid Drugs 0.000 description 2
- YHWUAHBJOFEABO-UHFFFAOYSA-N CCCCO[Cr]([O-])(=O)=O Chemical group CCCCO[Cr]([O-])(=O)=O YHWUAHBJOFEABO-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- IQSZJQFRQRWJJA-PQNPWOQQSA-N S(=O)(=O)(C)OC1[C@@H]2[C@](CC1)(C)CC[C@H]1[C@H]2CC[C@H]2CCCC[C@]12C Chemical compound S(=O)(=O)(C)OC1[C@@H]2[C@](CC1)(C)CC[C@H]1[C@H]2CC[C@H]2CCCC[C@]12C IQSZJQFRQRWJJA-PQNPWOQQSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N sulfonic acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- YNUYWCOVJOACSH-XJIZNKBASA-N (5R,8S,9S,10S,13S,14S)-10,13-dimethyl-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-one Chemical compound C1CCC[C@@H]2CC(=O)[C@H]3[C@@H]4CCC[C@@]4(C)CC[C@@H]3[C@]21C YNUYWCOVJOACSH-XJIZNKBASA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- AEMFNILZOJDQLW-QAGGRKNESA-N Androstenedione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N Cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N Dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- WEDQOCWDNTUDQH-LVOKNVKPSA-N O=C1C[C@@H]2CC([C@@H]3[C@H](CC[C@@]4(C(CC[C@H]43)=O)C)[C@]2(CC1)C)O Chemical class O=C1C[C@@H]2CC([C@@H]3[C@H](CC[C@@]4(C(CC[C@H]43)=O)C)[C@]2(CC1)C)O WEDQOCWDNTUDQH-LVOKNVKPSA-N 0.000 description 1
- GUCUXPJTVXMEKL-QFSSQGEMSA-N OC1[C@@H]2[C@H](CC[C@@]3(CCC[C@H]32)C)[C@]3(CCCC[C@@H]3C1)C Chemical compound OC1[C@@H]2[C@H](CC[C@@]3(CCC[C@H]32)C)[C@]3(CCCC[C@@H]3C1)C GUCUXPJTVXMEKL-QFSSQGEMSA-N 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical class CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE512653A true BE512653A (nl) |
Family
ID=151030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE512653D BE512653A (nl) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE512653A (nl) |
-
0
- BE BE512653D patent/BE512653A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0310519B1 (fr) | Nouveaux esters d'acide androstane 17-carboxylique, procédé pour leur préparation et médicament les contenant | |
CH652726A5 (fr) | Derives steroides 17-oxazolines, leur procede de preparation et leur utilisation a la preparation de corticosteroides. | |
EP0101383B1 (fr) | Dérivés d'amino-14 stéroides, application en thérapeutique, et procédé de préparation | |
BE512653A (nl) | ||
EP0192288B1 (fr) | Nouveaux dérivés stéroides portant en 17 un radical nitrométhylène, Leur application à la préparation de produits biologiquement actifs | |
EP0044575B1 (fr) | Produits intermédiaires dans la synthèse de 19-nor stéroides substitués en position 2 | |
CA1096372A (fr) | Procede de preparation de nouveaux 2,2-dimethyl 19- nor steroides | |
CH646983A5 (fr) | Derives acetyleniques chlores de l'androst-4-ene, leur preparation et medicaments les renfermant. | |
BE594849A (nl) | ||
BE515882A (nl) | ||
BE570698A (nl) | ||
BE517411A (nl) | ||
BE560182A (nl) | ||
BE497200A (nl) | ||
BE665139A (nl) | ||
BE560670A (nl) | ||
BE570470A (nl) | ||
CH616437A5 (en) | Process for the preparation of 3,20-diketopregnenes having an 11beta-acetal group and their derivatives | |
BE552152A (nl) | ||
BE727737A (nl) | ||
BE482452A (nl) | ||
BE528864A (nl) | ||
BE548024A (nl) | ||
BE515881A (nl) | ||
BE621941A (nl) |